Published by Benjamin Chiou on 10th December 2025
(Sharecast News) - GSK's risvutatug rezetecan has received Orphan Drug Designation from US regulators for the treatment of small-cell lung cancer, the UK pharma group announced on Wednesday.
URL: http://www.digitallook.com/dl/news/story/35552326/...